These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26524629)

  • 1. Deciphering structure-activity relationships in a series of Tat/TAR inhibitors.
    Pascale L; González AL; Di Giorgio A; Gaysinski M; Teixido Closa J; Tejedor RE; Azoulay S; Patino N
    J Biomol Struct Dyn; 2016 Nov; 34(11):2327-38. PubMed ID: 26524629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
    Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
    Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
    Bonnard V; Pascale L; Azoulay S; Di Giorgio A; Rogez-Kreuz C; Storck K; Clayette P; Patino N
    Bioorg Med Chem; 2010 Nov; 18(21):7432-8. PubMed ID: 20889349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J; Nguyen L; Zhao L; Xia T; Qi X
    Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
    Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
    Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing interaction of a fluorescent ligand with HIV TAR RNA.
    Qi L; Zhang J; He T; Huo Y; Zhang ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamics of peptide-RNA recognition: the binding of a Tat peptide to TAR RNA.
    Suryawanshi H; Sabharwal H; Maiti S
    J Phys Chem B; 2010 Sep; 114(34):11155-63. PubMed ID: 20687526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
    Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
    J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
    Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
    Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA.
    Murchie AI; Davis B; Isel C; Afshar M; Drysdale MJ; Bower J; Potter AJ; Starkey ID; Swarbrick TM; Mirza S; Prescott CD; Vaglio P; Aboul-ela F; Karn J
    J Mol Biol; 2004 Feb; 336(3):625-38. PubMed ID: 15095977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics and solvation dynamics of BIV TAR RNA-Tat peptide interaction.
    Goel T; Kumar S; Maiti S
    Mol Biosyst; 2013 Jan; 9(1):88-98. PubMed ID: 23114563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
    Wang Z; Rana TM
    Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus.
    Athanassiou Z; Patora K; Dias RL; Moehle K; Robinson JA; Varani G
    Biochemistry; 2007 Jan; 46(3):741-51. PubMed ID: 17223695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
    Zhao H; Li J; Jiang L
    Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein.
    Davidson A; Patora-Komisarska K; Robinson JA; Varani G
    Nucleic Acids Res; 2011 Jan; 39(1):248-56. PubMed ID: 20724442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.